Gene variation in resistant hypertension: Multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes

DNA and Cell Biology

Volumn 30, Issue 8, 2011, Pages 555-564

  Yugar Toledo, Juan Carlos ^a   Martin, José Fernando Vilela ^b   Krieger, José Eduardo ^c   Pereira, Alexandre C ^c   Demacq, Caroline ^a   Coelho, Otávio Rizzi ^a   Pimenta, Eduardo ^d   Calhoun, David A ^e   Moreno Jr , Heitor M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ACE GENE; ADULT; AGE; AGT GENE; ALLELE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NOS 3 GENE; PRIORITY JOURNAL; RISK FACTOR;

ANGIOTENSINOGEN; CASE-CONTROL STUDIES; DRUG RESISTANCE; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENETIC MARKERS; GENOTYPE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIFACTOR DIMENSIONALITY REDUCTION; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 79960935778     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1156     Document Type: Article

References (62)

1. Agerholm-Larsen, B., Nordestgaard, B.G., and Tybjaerg-Hansen, A. (2000).ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20, 484-492. (Pubitemid 30086107)
2. Agerholm-Larsen, B., Nordestgaard, B.G., Steffensen, R., Sorensen, T.I., Jensen, G., and Tybjaerg-Hansen, A. (1997).ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95, 2358-2367.
3. Bonnardeaux, A., Nadaud, S., Charru, A., Jeunemaitre, X., Corvol, P., and Soubrier, F. (1995).Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91, 96-102.
4. Brand, E., Chatelain, N., Keavney, B., Caulfield, M., Citterio, L., Connell, J., et al.1998).Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 31, 725-729. (Pubitemid 28108568)
5. Calhoun, D.A., Jones, D., Textor, S., Goff, D.C., Murphy, T.P., Toto, R.D., et al.2008).Resistant hypertension: diagnosis, evaluation, and treatment. a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51, 1403-1419.
6. Caulfield, M., Lavender, P., Farrall, M., Munroe, P., Lawson, M., Turner, P., et al.1994).Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330, 1629-1633. (Pubitemid 24166862)
7. Crisan, D., and Carr, J. (2000).Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn 2, 105-115.
8. Danser, A.H., and Schunkert, H. (2000).Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol 410, 303-316. (Pubitemid 32008152)
9. de Souza, W.A., Yugar-Toledo, J.C., Bergsten-Mendes, G., Sabha, M., and Moreno, H., Jr. (2007).Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm 64, 1955-1961. (Pubitemid 47462912)
10. Fabris, B., Bortoletto, M., Candido, R., Barbone, F., Cattin, M.R., Calci, M., et al.2005).Genetic polymorphisms of the reninangiotensin- aldosterone system and renal insufficiency in essential hypertension. J Hypertens 23, 309-316. (Pubitemid 40279634)
11. Freitas, S.R., Cabello, P.H., Moura-Neto, R.S., Dolinsky, L.C., Lima, A.B., Barros, M., et al.2007).Analysis of renin-angiotensin- aldosterone system gene polymorphisms in resistant hypertension. Braz J Med Biol Res 40, 309-316. (Pubitemid 46403601)
12. Hahn, L.W., Ritchie, M.D., and Moore, J.H. (2003).Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376-382. (Pubitemid 36284937)
13. Hahntow, I.N., Mairuhu, G., van Valkengoed, I.G., Koopmans, R.P., and Michel, M.C. (2010).Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension? BMC Cardiovasc Disord 10, 23.
14. Jachymova, M., Horky, K., Bultas, J., Kozich, V., Jindra, A., Peleska, J., et al.2001).Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 284, 426-430. (Pubitemid 32917993)
15. Jeunemaitre, X., Charru, A., Chatellier, G., Dumont, C., Sassano, P., Soubrier, F., et al.1993).M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens Suppl 11, S80-S81. (Pubitemid 24024708)
16. Ji, L.D., Zhang, L.N., Shen, P., Wang, P., Zhang, Y.M., Xing, W.H., et al.2010).Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis. J Hypertens 28, 419-428.
17. Kaplan, N.M. (2005).Resistant hypertension. J Hypertens 23, 1441-1444. (Pubitemid 41104810)
18. Karvonen, J., Kauma, H., Kervinen, K., Rantala, M., Ikaheimo, M., Paivansalo, M., et al.2002).Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population- based cohort. J Intern Med 251, 102-110. (Pubitemid 34146692)
19. Kato, N., Sugiyama, T., Morita, H., Nabika, T., Kurihara, H., Yamori, Y., et al.1999).Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33, 933-936. (Pubitemid 29186387)
20. Kiema, T.R., Kauma, H., Rantala, A.O., Lilja, M., Reunanen, A., Kesaniemi, Y.A., et al.1996).Variation at the angiotensinconverting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 28, 1070-1075. (Pubitemid 26415826)
21. Konoshita, T., Kato, N., Fuchs, S., Mizuno, S., Aoyama, C., Motomura, M., et al.2009).Genetic variant of the Renin- Angiotensin system and diabetes influences blood pressure response to Angiotensin receptor blockers. Diabetes Care 32, 1485-1490.
22. Kunz, R., Kreutz, R., Beige, J., Distler, A., and Sharma, A.M. (1997).Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 30, 1331-1337. (Pubitemid 27528071)
23. Lacolley, P., Gautier, S., Poirier, O., Pannier, B., Cambien, F., and Benetos, A. (1998).Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16, 31-35. (Pubitemid 28069817)
24. Lanz, J.R., Pereira, A.C., Lemos, P.A., Martinez, E., and Krieger, J.E. (2005).Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta 362, 176-181. (Pubitemid 41597103)
25. Marsden, P.A., Heng, H.H., Scherer, S.W., Stewart, R.J., Hall, A.V., Shi, X.M., et al.1993).Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268, 17478-17488. (Pubitemid 23236991)
26. Mei, H., Cuccaro, M.L., and Martin, E.R. (2007).Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables. Am J Hum Genet 81, 1251-1261. (Pubitemid 350211453)
27. Miyamoto, Y., Saito, Y., Kajiyama, N., Yoshimura, M., Shimasaki, Y., Nakayama, M., et al.1998).Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32, 3-8. (Pubitemid 28324117)
28. Mondry, A., Loh, M., Liu, P., Zhu, A.L., and Nagel, M. (2005). Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 6, 1.
29. Moser, M., and Setaro, J.F. (2006).Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med 355, 385-392. (Pubitemid 44127541)
30. Nair, K.G., Shalia, K.K., Ashavaid, T.F., and Dalal, J.J. (2003). Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal 17, 141-146. (Pubitemid 37128652)
31. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. (1989).Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874-879.
32. Pander, J., Wessels, J.A., Mathijssen, R.H., Gelderblom, H., and Guchelaar, H.J. (2010).Pharmacogenetics of tomorrow: the 1-3 principle. Pharmacogenomics 11, 1011-1017.
33. Pereira, A.C., Mota, G.A., Bensenor, I., Lotufo, P.A., and Krieger, J.E. (2001).Effect of race, genetic population structure, and genetic models in two-locus association studies: clustering of functional renin-angiotensin system gene variants in hypertension association studies. Braz J Med Biol Res 34, 1421-1428. (Pubitemid 34036844)
34. Pereira, A.C., Mota, G.F., Cunha, R.S., Herbenhoff, F.L., Mill, J.G., and Krieger, J.E. (2003).Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes. Hypertension 41, 25-30. (Pubitemid 36056787)
35. Pereira, A.C., Sposito, A.C., Mota, G.F., Cunha, R.S., Herkenhoff, F.L., Mill, J.G., et al.2006).Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. Atherosclerosis 184, 193-200. (Pubitemid 41721088)
36. Pimenta, E., Gaddam, K.K., Pratt-Ubunama, M.N., Nishizaka, M.K., Aban, I., Oparil, S., et al.2008).Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension 51, 339-344. (Pubitemid 351159948)
37. Procopciuc, L.M., Sitar-Taut, A., Pop, D., Sitar-Taut, D.A., Olteanu, I., and Zdrenghea, D. (2010).Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS). Eur J Intern Med 21, 414-418.
38. Renner, W., Nauck, M., Winkelmann, B.R., Hoffmann, M.M., Scharnagl, H., Mayer, V., et al.2005).Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med 83, 235-239. (Pubitemid 40487412)
39. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. (1990).An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 1343-1346. (Pubitemid 20370444)
40. Ritchie, M.D. (2005).Bioinformatics approaches for detecting gene-gene and gene-environment interactions in studies of human disease. Neurosurg Focus 19, E2.
41. Ritchie, M.D., Hahn, L.W., and Moore, J.H. (2003).Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24, 150-157. (Pubitemid 36158211)
42. Ritchie, M.D., Hahn, L.W., Roodi, N., Bailey, L.R., Dupont, W.D., Parl, F.F., et al.2001).Multifactor-dimensionality reduction reveals high-order interactions among estrogenmetabolism genes in sporadic breast cancer. Am J Hum Genet 69, 138-147. (Pubitemid 32614026)
43. Russ, A.P., Maerz, W., Ruzicka, V., Stein, U., and Gross, W. (1993).Rapid detection of the hypertension-associated Met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 2, 609-610. (Pubitemid 23140035)
44. Sekuri, C., Cam, F.S., Ercan, E., Tengiz, I., Sagcan, A., Eser, E., et al.2005).Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst 6, 38-42. (Pubitemid 40796847)
45. Sessa, W.C., Harrison, J.K., Barber, C.M., Zeng, D., Durieux, M.E., D'Angelo, D.D., et al.1992).Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267, 15274-15276.
46. Sethi, A.A., Nordestgaard, B.G., Agerholm-Larsen, B., Frandsen, E., Jensen, G., and Tybjaerg-Hansen, A. (2001).Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study. Hypertension 37, 875-881. (Pubitemid 32221607)
47. Sethi, A.A., Nordestgaard, B.G., Gronholdt, M.L., Steffensen, R., Jensen, G., and Tybjaerg-Hansen, A. (2003a).Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 41, 1202-1211. (Pubitemid 36706066)
48. Sethi, A.A., Nordestgaard, B.G., and Tybjaerg-Hansen, A. (2003b).Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 23, 1269-1275. (Pubitemid 36871283)
49. Shanmugam, V., Sell, K.W., and Saha, B.K. (1993).Mistyping ACE heterozygotes. PCR Methods Appl 3, 120-121
50. Siani, A., Russo, P., Paolo Cappuccio, F., Iacone, R., Venezia, A., Russo, O., et al.2004).Combination of renin-angiotensin system polymorphisms is associated with altered renal sodium handling and hypertension. Hypertension 43, 598-602. (Pubitemid 38282434)
51. Sober, S., Org, E., Kepp, K., Juhanson, P., Eyheramendy, S., Gieger, C., et al.2009).Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One 4, e6034.
52. Sposito, A.C., Caramelli, B., Fonseca, F.A., Bertolami, M.C., Afiune Neto, A., Souza, A.D., et al.2007).[IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology]. Arq Bras Cardiol 88 Suppl 1, 2-19. (Pubitemid 47164157)
53. Stankovic, A., Zivkovic, M., and Alavantic, D. (2002).Angiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension. Scand J Clin Lab Invest 62, 469-475.
54. Strazzullo, P., D'Elia, L., Kandala, N.B., and Cappuccio, F.P. (2009).Salt intake, stroke, and cardiovascular disease: metaanalysis of prospective studies. BMJ 339, b4567.
55. Takahashi, N., Hagaman, J.R., Kim, H.S., and Smithies, O. (2003).Minireview: computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 144, 2184-2190. (Pubitemid 36629864)
56. Takeuchi, F., Isono, M., Katsuya, T., Yamamoto, K., Yokota, M., Sugiyama, T., et al.2010).Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation 121, 2302-2309.
57. Thomas, G.D., Zhang, W., and Victor, R.G. (2001).Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA 285, 2055-2057. (Pubitemid 32367811)
58. Thomas, G.N., Young, R.P., Tomlinson, B., Woo, K.S., Sanderson, J.E., and Critchley, J.A. (2000).Renin-angiotensinaldosterone system gene polymorphisms and hypertension in Hong Kong Chinese. Clin Exp Hypertens 22, 87-97. (Pubitemid 30090950)
59. Wang, Y., and Wang, J.Q. (2000).Standard definition of child overweight and obesity worldwide. Authors' standard compares well wil WHO standard. BMJ 321, 1158.
60. Wolff, B., Grabe, H.J., Schluter, C., Popowski, K., Volzke, H., Ludemann, J., et al.2005).Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J Hypertens 23, 1361-1366. (Pubitemid 40933956)
61. Wu, C.K., Luo, J.L., Tsai, C.T., Huang, Y.T., Cheng, C.L., Lee, J.K., et al.2010).Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J 10, 46-53.
62. Zafarmand, M.H., van der Schouw, Y.T., Grobbee, D.E., de Leeuw, P.W., and Bots, M.L. (2008).The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy- Weinberg equilibrium violation and publication bias in a meta-analysis. PLoS One 3, e2533.